Key result
Management of iron deficiency and anaemia in the perioperative setting remains a matter of debate, though treating pre-operative anaemia may offer significant economic savings and reduce mortality.
Preoperative management of iron deficiency and anaemia in cardiac surgery remains debated despite known risks of perioperative mortality and potential economic savings.
It is well-established that pre-operative anaemia, major bleedings and red blood cell (RBC) transfusions are risk factors for perioperative mortality, especially after cardiac surgery (1). It has been estimated an important economic saving (about US $78–97 million) when preoperative measures are undertaken for treating anaemia compared to the use of RBC transfusion during hospital stay (2,3). Management of iron deficiency and anaemia in the perioperative setting is still a matter of debate and several authors have tried to define different strategies.
No takes yet. Share an insight, caveat, or question.
Rolli et al. (2019) conducted an editorial in Pre-operative anaemia and iron deficiency. Preoperative treatment of anaemia vs. Red blood cell transfusion during hospital stay was evaluated. Management of iron deficiency and anaemia in the perioperative setting remains a matter of debate, though treating pre-operative anaemia may offer significant economic savings and reduce mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: